Yes, and that’s an increasingly important area where live blood analysis, especially using darkfield microscopy, is starting to show real promise, not as a diagnostic tool in the traditional sense, but as a supportive, observational tool.
With the emergence of mRNA-based therapies during the COVID era, and the growing number of people reporting persistent symptoms after infection or vaccination, many integrative practitioners, myself included, have turned to live blood analysis to explore what’s happening at a deeper, more cellular level.
Although we work with very high levels of magnification in darkfield, we can’t see spike protein itself, because that would require us to look at the molecular level. What’s become clear however, is that we can see the effects of spike protein with darkfield microscopy, and what’s more is that we’re seeing these patterns in real-time. This has made LBA especially useful as a tool to test various treatment strategies for patients affected by this condition, and has allowed for effective protocols to be developed.
For example, we used this approach to monitor patients on enzymes like Nattokinase, lumbrokinase and serrapeptase, which help break down microclots; or antioxidants like glutathione and NAC to reduce oxidative stress. What we have consistently seen is a gradual return to healthier blood morphology, less clumping, healthier cells and fewer foreign particles, which corresponds to improvements in how the patient feels.
It’s also a great motivator for the patient. When they can see their blood improve on-screen, it’s incredibly empowering.
So, yes, live blood analysis does help to address covid health issues and has actually been instrumental in vaccine injury research, where it’s been used to help understand this condition better, and to develop effective interventions.